H.B. No. 1304 introduces new labeling requirements for products containing or derived from aborted human fetal tissue in Texas. The bill amends the Health and Safety Code by adding three sections: 431.085 for food products, 431.118 for medical products, and 431.143 for cosmetic products. Each section defines what constitutes a "fetal tissue product" and mandates that such products cannot be sold, dispensed, or administered unless they are clearly labeled according to rules set by the executive commissioner of the Health and Human Services Commission. The definitions include products that contain, are manufactured using, or are derived from human fetal tissue, which is specified as tissue, cells, or organs obtained from an aborted unborn child.

The executive commissioner is required to adopt the form and content of the labels by December 1, 2025, and these labeling requirements will apply to products sold or administered on or after January 1, 2026. The bill stipulates that it will take effect immediately if it receives a two-thirds vote from both houses; otherwise, it will take effect on September 1, 2025.

Statutes affected:
Introduced: ()